UCSF Study Finds Drug Abuse Treatment Programs Can Be Effective in Changing High-Risk Behavior for HIV

November 08, 1999

Drug users participating in a treatment program based on a "therapeutic community" model showed a decrease in HIV-related high risk behavior, according to a new study by University of California, San Francisco AIDS researchers.

The study found that program participants made positive behavior changes in both drug injection use and high-risk sex.

One of the most notable findings was the correlation between length of time associated with treatment and decision-making regarding high-risk activity, said William J. Woods, PhD, study co-investigator and a research psychologist with the UCSF Center for AIDS Prevention Studies.

"We found that the longer the period of time spent in the treatment program, the less likelihood that a person would engage in the very high-risk behavior of needle sharing. We also saw this pattern in regard to high-risk sex , but it was not as significant as the correlation with high-risk drug activity," Woods said.

Research results are reported in the November issue of the journal AIDS. The study involved 261 clients in a drug treatment program at Walden House in San Francisco.

In the therapeutic community model, program staff members act as a surrogate family to help clients abolish behaviors related to drug use, develop self-esteem, and develop self-reliance, according to Woods. Treatment involves a variety of clinical and support services, such as individual, group, and family counseling, education and vocational services, and social and recreational activities. Treatment is structured to move participants from drug dependence to a drug-free lifestyle.

Study participants were assigned either to the day program, in which they returned to their homes each day, or to the residential program, with 24-hour-a-day structure. Participants included both men and women, ranging in age from 18 to 53 years. The primary drug of choice was cocaine for 67 percent of participants and heroin for 13 percent.

From the early days of the AIDS epidemic, injection drug users (IDUs) were identified as a group at risk for HIV infection through the sharing of needles and other drug paraphernalia, with later studies showing that IDUs and their sexual partners also were at increased risk of HIV through sexual behaviors, Woods noted. As the epidemic continued, it became known that substance abusers who did not inject drugs also were at greater risk of HIV infection than the general population because of high-risk sexual practices.

"Now recent evaluations have concluded that methadone maintenance programs reduce needle use among drug users, but the evidence has been less clear about the value of other treatment modalities in reducing HIV risk among both IDUs and non-IDUs. So our objective was to measure this value," Woods said.

Study participants were interviewed about high-risk behaviors at the beginning of the treatment program and then at 6, 12, and 18 months.

Among the study findings:

Joseph R. Guydish, PhD, associate professor with the UCSF Institute for Health Policy Studies, was study principal investigator. Co-investigators included James L. Sorensen, PhD, Department of Psychiatry at UCSF and San Francisco General Hospital Medical Center; Adam Coutts, BA, UCSF Department of Medicine; Alan Bostrom, PhD, UCSF Department of Social and Behavioral Sciences; and Alfonso Acampora, MBA, Walden House, Inc.

The research was supported by a grant from the National Institute on Drug Abuse.
-end-


University of California - San Francisco

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.